• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素通过泛素激活酶 E1 样蛋白部分防止 ISG15 的激活,并降低 ISG 化。

Curcumin partly prevents ISG15 activation via ubiquitin-activating enzyme E1-like protein and decreases ISGylation.

机构信息

Department of Biochemistry, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, 060-8638, Japan.

Department of Food and Health Sciences, International College of Arts and Sciences, Fukuoka Women's University, Fukuoka, 813-8582, Japan.

出版信息

Biochem Biophys Res Commun. 2022 Oct 15;625:94-101. doi: 10.1016/j.bbrc.2022.08.003. Epub 2022 Aug 5.

DOI:10.1016/j.bbrc.2022.08.003
PMID:35952613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9352433/
Abstract

The expression of the ubiquitin-like molecule interferon-stimulated gene 15 kDa (ISG15) and post-translational protein modification by ISG15 (ISGylation) are strongly activated by interferons or pathogen infection, suggesting that ISG15 and ISGylation play an important role in innate immune responses. More than 400 proteins have been found to be ISGylated. ISG15 is removed from substrates by interferon-induced ubiquitin-specific peptidase 18 or severe acute respiratory syndrome coronavirus 2‒derived papain-like protease. Therefore, maintaining strong ISGylation may help prevent the spread of coronavirus disease 2019 (COVID-19). However, it is unknown whether nutrients or chemicals affect ISGylation level. Curcumin is the major constituent of turmeric and functions as an immunomodulator. Here, we investigated the effect of curcumin on ISGylation. MCF10A and A549 cells were treated with interferon α and curcumin after which the expression levels of various proteins were determined. The effect of curcumin on ubiquitylation was also determined. Curcumin treatment was found to reduce ISGylation in a dose-dependent manner. The findings suggested that curcumin partly prevents disulfide bond-mediated ISG15 dimerization directly or indirectly, thereby increasing monomer ISG15 levels. Reduced ISGylation may also occur via the prevention of ISG15 activation by ubiquitin-activating enzyme E1-like protein. In conclusion, curcumin treatment was found to reduce ISGylation, suggesting that it may contribute to severe COVID-19. This is the first study to report a relationship between ISGylation and a food component.

摘要

干扰素刺激基因 15kDa(ISG15)的泛素样分子表达和 ISG15 的翻译后蛋白修饰(ISGylation)在干扰素或病原体感染下强烈激活,这表明 ISG15 和 ISGylation 在先天免疫反应中发挥着重要作用。已经发现超过 400 种蛋白质被 ISGylation。干扰素诱导的泛素特异性肽酶 18 或严重急性呼吸综合征冠状病毒 2 衍生的木瓜蛋白酶样蛋白酶将 ISG15 从底物中去除。因此,保持强烈的 ISGylation 可能有助于阻止 2019 年冠状病毒病(COVID-19)的传播。然而,目前尚不清楚营养素或化学物质是否会影响 ISGylation 水平。姜黄素是姜黄的主要成分,具有免疫调节剂的作用。在这里,我们研究了姜黄素对 ISGylation 的影响。用干扰素 α 和姜黄素处理 MCF10A 和 A549 细胞,然后测定各种蛋白质的表达水平。还测定了姜黄素对泛素化的影响。结果发现,姜黄素处理以剂量依赖性方式降低 ISGylation。研究结果表明,姜黄素可能直接或间接地部分阻止二硫键介导的 ISG15 二聚化,从而增加单体 ISG15 水平。ISGylation 的减少也可能通过防止泛素激活酶 E1 样蛋白对 ISG15 的激活来发生。总之,姜黄素处理被发现降低了 ISGylation,这表明它可能导致严重的 COVID-19。这是第一项报道 ISGylation 与食物成分之间关系的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d1/9352433/1152ee90080f/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d1/9352433/0fdf71d1d6f7/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d1/9352433/78279da86274/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d1/9352433/e84954ca8586/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d1/9352433/661fa296c803/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d1/9352433/1152ee90080f/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d1/9352433/0fdf71d1d6f7/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d1/9352433/78279da86274/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d1/9352433/e84954ca8586/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d1/9352433/661fa296c803/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d1/9352433/1152ee90080f/gr5_lrg.jpg

相似文献

1
Curcumin partly prevents ISG15 activation via ubiquitin-activating enzyme E1-like protein and decreases ISGylation.姜黄素通过泛素激活酶 E1 样蛋白部分防止 ISG15 的激活,并降低 ISG 化。
Biochem Biophys Res Commun. 2022 Oct 15;625:94-101. doi: 10.1016/j.bbrc.2022.08.003. Epub 2022 Aug 5.
2
Free ISG15 and Protein ISGylation Emerging in SARS-CoV-2 Infection.新冠病毒感染中游离的 ISG15 和蛋白质的 ISG 化修饰。
Curr Drug Targets. 2022;23(7):686-691. doi: 10.2174/1389450123666220316094720.
3
Protein interferon-stimulated gene 15 conjugation delays but does not overcome coronavirus proliferation in a model of fulminant hepatitis.蛋白干扰素刺激基因 15 缀合延迟但不能克服暴发性肝炎模型中的冠状病毒增殖。
J Virol. 2014 Jun;88(11):6195-204. doi: 10.1128/JVI.03801-13. Epub 2014 Mar 19.
4
SARS-CoV-2 papain-like protease inhibits ISGylation of the viral nucleocapsid protein to evade host anti-viral immunity.SARS-CoV-2 木瓜蛋白酶样蛋白酶抑制病毒核衣壳蛋白的 ISG 化,从而逃避宿主抗病毒免疫。
J Virol. 2024 Sep 17;98(9):e0085524. doi: 10.1128/jvi.00855-24. Epub 2024 Aug 9.
5
Interferon-stimulated gene 15 and the protein ISGylation system.干扰素刺激基因 15 和蛋白质 ISGylation 系统。
J Interferon Cytokine Res. 2011 Jan;31(1):119-30. doi: 10.1089/jir.2010.0110. Epub 2010 Dec 29.
6
Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation.干扰素诱导的泛素E2,Ubc8,是一种用于蛋白质ISGylation的缀合酶。
Mol Cell Biol. 2004 Nov;24(21):9592-600. doi: 10.1128/MCB.24.21.9592-9600.2004.
7
ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis.HERC5 对 SARS-CoV-2 N 蛋白的 ISGylation 抑制了 N 蛋白寡聚化,从而抑制了病毒 RNA 的合成。
J Virol. 2024 Sep 17;98(9):e0086924. doi: 10.1128/jvi.00869-24. Epub 2024 Aug 28.
8
Interferon-Stimulated Gene 15 Conjugation Stimulates Hepatitis B Virus Production Independent of Type I Interferon Signaling Pathway .干扰素刺激基因15的缀合作用可刺激乙型肝炎病毒产生,且不依赖于I型干扰素信号通路。
Mediators Inflamm. 2016;2016:7417648. doi: 10.1155/2016/7417648. Epub 2016 Oct 27.
9
Nitrosylation of ISG15 prevents the disulfide bond-mediated dimerization of ISG15 and contributes to effective ISGylation.ISG15的亚硝基化可防止ISG15通过二硫键介导的二聚化,并有助于有效的ISGylation。
J Biol Chem. 2008 Sep 5;283(36):24484-8. doi: 10.1074/jbc.M803795200. Epub 2008 Jul 7.
10
Transmembrane Protein pUL50 of Human Cytomegalovirus Inhibits ISGylation by Downregulating UBE1L.人巨细胞病毒跨膜蛋白 pUL50 通过下调 UBE1L 抑制 ISGylation
J Virol. 2018 Jul 17;92(15). doi: 10.1128/JVI.00462-18. Print 2018 Aug 1.

引用本文的文献

1
Spermidine reduces ISGylation and enhances ISG15-USP18 interaction.亚精胺可减少ISGylation并增强ISG15-USP18的相互作用。
Sci Rep. 2025 May 23;15(1):17913. doi: 10.1038/s41598-025-01425-0.
2
Protein ISGylation: a posttranslational modification with implications for malignant neoplasms.蛋白质ISGylation:一种对恶性肿瘤有影响的翻译后修饰。
Explor Target Antitumor Ther. 2023;4(4):699-715. doi: 10.37349/etat.2023.00162. Epub 2023 Aug 31.

本文引用的文献

1
Viral and cellular translation during SARS-CoV-2 infection.SARS-CoV-2 感染期间的病毒和细胞翻译。
FEBS Open Bio. 2022 Sep;12(9):1584-1601. doi: 10.1002/2211-5463.13413. Epub 2022 Apr 25.
2
An overview of potential inhibitors targeting non-structural proteins 3 (PL and Mac1) and 5 (3CL/M) of SARS-CoV-2.靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白3(PL和Mac1)和5(3CL/M)的潜在抑制剂概述。
Comput Struct Biotechnol J. 2021;19:4868-4883. doi: 10.1016/j.csbj.2021.08.036. Epub 2021 Aug 24.
3
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors.
高通量筛选鉴定出已上市药物为 SARS-CoV-2 PLpro 抑制剂。
Protein Cell. 2021 Nov;12(11):877-888. doi: 10.1007/s13238-021-00836-9. Epub 2021 Apr 17.
4
The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery.GRL0617 与 SARS-CoV-2 PLpro 的复杂结构揭示了抗病毒药物发现的热点。
Nat Commun. 2021 Jan 20;12(1):488. doi: 10.1038/s41467-020-20718-8.
5
Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL and PL), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2).类黄酮作为针对 SARS-CoV-2 蛋白酶(3CL 和 PL)、刺突蛋白、RNA 依赖性 RNA 聚合酶(RdRp)和血管紧张素转换酶 II 受体(ACE2)的潜在抗病毒药物。
Eur J Pharmacol. 2021 Jan 15;891:173759. doi: 10.1016/j.ejphar.2020.173759. Epub 2020 Nov 27.
6
Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.靶向蛋白酶的 COVID-19 药物发现及其挑战:对病毒主蛋白酶(Mpro)和木瓜蛋白酶样蛋白酶(PLpro)抑制剂的深入了解。
Bioorg Med Chem. 2021 Jan 1;29:115860. doi: 10.1016/j.bmc.2020.115860. Epub 2020 Nov 6.
7
Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.SARS-CoV-2 木瓜蛋白酶样蛋白酶(PLpro)的作用机制及抑制作用。
EMBO J. 2020 Sep 15;39(18):e106275. doi: 10.15252/embj.2020106275. Epub 2020 Aug 26.
8
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.木瓜蛋白酶样蛋白酶调节新型冠状病毒2的病毒传播和固有免疫。
Nature. 2020 Nov;587(7835):657-662. doi: 10.1038/s41586-020-2601-5. Epub 2020 Jul 29.
9
Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19.冠状病毒中的去泛素化酶及 COVID-19 的可能治疗机会。
Int J Mol Sci. 2020 May 15;21(10):3492. doi: 10.3390/ijms21103492.
10
Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.新型冠状病毒木瓜样蛋白酶的去泛素酶和去ISG15酶活性的表征及非共价抑制作用
ACS Infect Dis. 2020 Aug 14;6(8):2099-2109. doi: 10.1021/acsinfecdis.0c00168. Epub 2020 Jun 4.